The<unk>  (TT), also known as the thrombin clotting time (TCT) is a blood test that measures the time it takes for a clot to form in the plasma of a blood sample containing anticoagulant, after an excess of thrombin has been added. It is used to diagnose blood coagulation disorders and to assess the effectiveness of fibrinolytic therapy. This test is repeated with pooled plasma from normal patients. The difference in time between the test and the 'normal' indicates an abnormality in the conversion of fibrinogen (a soluble protein) to fibrin, an insoluble protein. The<unk>  compares the rate of clot formation to that of a sample of normal pooled plasma. Thrombin is added to the samples of plasma. If the time it takes for the plasma to clot is prolonged, a quantitative (fibrinogen deficiency) or qualitative (dysfunctional fibrinogen) defect is present. In blood samples containing heparin, a substance derived from snake venom called batroxobin (formerly reptilase) is used instead of thrombin. Batroxobin has a similar action to thrombin but unlike thrombin it is not inhibited by heparin. Normal values for<unk>  are 12 to 14 seconds. If batroxobin is used, the time should be between 15 and 20 seconds.<unk>  can be prolonged by heparin, fibrin degradation products, and fibrinogen deficiency or abnormality.
Thrombin time
Activated clotting time
Prothrombin time
Partial thromboplastin time
Kaolin clotting time
Ecarin clotting time
Thrombin generation assay
Reptilase time